Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 9/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 5/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL698817 | 1.00 | HCAR2 (0.58) | HCAR2THRBTSHRATMPOLB | |
| SCHEMBL1886812 | 1.00 | HCAR2 (0.58) | HCAR2THRBTSHRATMPOLB | |
| SCHEMBL194313 | 1.00 | HCAR2 (0.58) | HCAR2THRBTSHRATMPOLB | |
| SCHEMBL28190015 | 0.98 | HCAR2 (0.56) | HCAR2THRBTSHRATMPOLB | |
| SCHEMBL19064242 | 0.93 | HCAR2 (0.51) | HCAR2THRBTSHRATMALDH1A1 | |
| SCHEMBL195022 | 0.93 | HCAR2 (0.61) | HCAR2THRBTSHRATMPOLB | |
| SCHEMBL9514358 | 0.93 | HCAR2 (0.61) | HCAR2THRBTSHRATMPOLB | |
| SCHEMBL195182 | 0.93 | HCAR2 (0.64) | HCAR2THRBTSHRATMPOLB | |
| SCHEMBL1696753 | 0.92 | THRB (0.59) | HCAR2THRBTSHRATMPOLB | |
| SCHEMBL9155949 | 0.92 | THRB (0.59) | HCAR2THRBTSHRATMPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10907062-B2 | Oil-based inkjet ink and method for producing oil-based inkjet ink | RISO KAGAKU CORPORATION (JP) | 2021-02-02 | — | — | US | disclosed |
| EP-3587518-B1 | OIL-BASED INKJET INK AND METHOD FOR PRODUCING OIL-BASED INKJET INK | RISO KAGAKU CORP (JP) | 2020-12-16 | — | — | EP | disclosed |
| EP-3301137-B1 | COLORED RESIN PARTICLE DISPERSION | RISO KAGAKU CORP (JP) | 2019-04-03 | — | — | EP | disclosed |
| US-10144839-B2 | Colored resin particle dispersion | RISO KAGAKU CORPORATION (JP) | 2018-12-04 | — | — | US | disclosed |
| EP-3301137-A1 | COLORED RESIN PARTICLE DISPERSION | Riso Kagaku Corporation (JP) | 2018-04-04 | — | — | EP | disclosed |
| US-20180086927-A1 | COLORED RESIN PARTICLE DISPERSION | RISO KAGAKU CORPORATION (JP) | 2018-03-29 | — | — | US | disclosed |
| US-8951616-B2 | Ester group containing liquid crystals for optical or electro optical devices | ROLIC AG (CH) | 2015-02-10 | — | — | US | disclosed |
| US-8951616-B2 | Ester group containing liquid crystals for optical or electro optical devices | ROLIC AG (CH) | 2015-02-10 | — | — | US | disclosed |
| US-20120114907-A1 | ESTER GROUP CONTAINING LIQUID CRYSTALS FOR OPTICAL OR ELECTRO OPTICAL DEVICES | ROLIC AG. (CH) | 2012-05-10 | — | — | US | disclosed |
| US-20120114907-A1 | ESTER GROUP CONTAINING LIQUID CRYSTALS FOR OPTICAL OR ELECTRO OPTICAL DEVICES | ROLIC AG. (CH) | 2012-05-10 | — | — | US | disclosed |
| US-20040010099-A1 | Using complex as free radical catalyst | LOCTITE (R&D) LTD. | 2004-01-15 | — | — | US | disclosed |
| US-20030226472-A1 | Polymerisation initiators, polymerisable compositions, and uses thereof for bonding low surface energy substrates | LOCTITE (R&D) LIMITED | 2003-12-11 | — | — | US | disclosed |
| WO-2003089536-A2 | POLYMERISATION INITIATORS BASED ON AMMONIUM TETRAALKYL BORANES, POLYMERISABLE COMPOSITIONS, AND USES THEREOF FOR BONDING LOW SURFACE ENERGY SUBSTRATES | LOCTITE (R & D) LIMITED (IE) | 2003-10-30 | — | — | WO | disclosed |
| US-6632908-B1 | Includes a (meth)acrylate component and an initiator system including an organometallic compound, a peroxy compound, an aziridine functionalized compound, and a compound having an acid functional group | HENKEL LOCTITE CORPORATION | 2003-10-14 | — | — | US | disclosed |
| EP-1328597-A1 | QUATERNARY BORON COMPOUND POLYMERISATION INITIATORS, POLYMERISABLE COMPOSITIONS AND USES THEREOF FOR BONDING LOW SURFACE ENERGY SUBSTRATES | Loctite (R & D) Limited (IE) | 2003-07-23 | — | — | EP | disclosed |
| US-20030038031-A1 | Coating composition containing benzoxazine compound | NIPPON PAINT CO., LTD. | 2003-02-27 | — | — | US | disclosed |
| EP-1247844-A2 | Coating composition containing benzoxazine compounds | Nippon Paint Co., Ltd. (JP) | 2002-10-09 | — | — | EP | disclosed |
| WO-2002034852-A1 | METAL ALKYL BOROHYDRIDE POLYMERISATION INITIATORS, POLYMERISABLE COMPOSITIONS, AND USES THEREOF | LOCTITE (R & D) LIMITED (IE) | 2002-05-02 | — | — | WO | disclosed |
| WO-2002034851-A1 | QUATERNARY BORON COMPOUND POLYMERISATION INITIATORS, POLYMERISABLE COMPOSITIONS, AND USES THEREOF FOR BONDING LOW SURFACE ENERGY SUBSTRATES | LOCTITE (R & D) LIMITED (IE) | 2002-05-02 | — | — | WO | disclosed |
| EP-1201722-A1 | Polymerisation initiators, polymerisable compositions, and uses thereof | Loctite (R & D) Limited (IE) | 2002-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120114907-A1 | ESTER GROUP CONTAINING LIQUID CRYSTALS FOR OPTICAL OR ELECTRO OPTICAL DEVICES | MLEC, CEL, AQP4 | HCAR2 2154/4885THRB 4614/4885TSHR 4752/4885 |
| US-20040010099-A1 | Using complex as free radical catalyst | CHRM1, CBR1, CHRM2 | HCAR2 356/4885THRB 837/4885TSHR 2082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.